IDEXX LABORATORIES INC /DE Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
IDEXX LABORATORIES INC /DE (IDXX) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $494.75 per share as of 2022-09-30, per its 10-Q filed 2022-11-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2022-11-01
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $494.75.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $499.09.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $509.95.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $550.10.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2022-09-30 | $494.75 10-Q · filed 2022-11-01 |
| 2022-06-30 | $499.09 10-Q · filed 2022-08-02 |
| 2022-03-31 | $509.95 10-Q · filed 2022-05-04 |
| 2021-12-31 | $550.10 10-K · filed 2022-02-16 |
| 2021-09-30 | $531.24 10-Q · filed 2022-11-01 |
| 2021-06-30 | $546.43 10-Q · filed 2022-08-02 |
| 2021-03-31 | $548.15 10-Q · filed 2022-05-04 |
| 2020-12-31 | $291.14 10-K · filed 2022-02-16 |
| 2019-12-31 | $220.88 10-K · filed 2022-02-16 |
| 2018-12-31 | $179.56 10-K · filed 2021-02-12 |
| 2017-12-31 | $142.89 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |